Literature DB >> 15094178

Treatment of recurrent small cell lung cancer.

Angela M Davies1, William K Evans, Jean A Mackay, Frances A Shepherd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15094178     DOI： 10.1016/j.hoc.2003.12.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


× No keyword cloud information.
  8 in total

Review 1.  Chemotherapy advances in small-cell lung cancer.

Authors:  Bryan A Chan; Jermaine I G Coward
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 2.  INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.

Authors:  Alberto A Chiappori; Hatem Soliman; William E Janssen; Scott J Antonia; Dmitry I Gabrilovich
Journal:  Expert Opin Biol Ther       Date:  2010-06       Impact factor: 4.388

Review 3.  Modern management of small-cell lung cancer.

Authors:  Roberta Ferraldeschi; Sofia Baka; Babita Jyoti; Corinne Faivre-Finn; Nick Thatcher; Paul Lorigan
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.

Authors:  Tatsuo Kimura; Shinzoh Kudoh; Kazuto Hirata
Journal:  Clin Med Insights Oncol       Date:  2011-03-03

5.  Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma.

Authors:  Min-Jung Lee; Yusuke Tomita; Akira Yuno; Sunmin Lee; Nacer E Abrouk; Bryan Oronsky; Scott Caroen; Jane B Trepel
Journal:  Expert Opin Investig Drugs       Date:  2021-01-11       Impact factor: 6.498

6.  Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer.

Authors:  Sonam Puri; Benjamin H Lok; Natasha Leighl; Jhanelle E Gray
Journal:  Front Oncol       Date:  2020-11-17       Impact factor: 6.244

7.  Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.

Authors:  Caroline Dive; Christopher J Morrow; Radosław Polański; Cassandra L Hodgkinson; Alberto Fusi; Daisuke Nonaka; Lynsey Priest; Paul Kelly; Francesca Trapani; Paul W Bishop; Anne White; Susan E Critchlow; Paul D Smith; Fiona Blackhall
Journal:  Clin Cancer Res       Date:  2013-11-25       Impact factor: 12.531

Review 8.  What's New in SCLC? A Review.

Authors:  Bryan Oronsky; Tony R Reid; Arnold Oronsky; Corey A Carter
Journal:  Neoplasia       Date:  2017-09-06       Impact factor: 5.715
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.